| Execution period | quarter ended 31st March 2026 |
|---|
BSE filing, BSE: 544483. Summary written from the filing by ALFA Finder's alert engine.
Icodex Publishing Solutions Ltd: key numbers
- Share price
- ₹35.52
- Market cap
- ₹55.54 Cr
- Revenue (annual)
- ₹25.93 Cr
- Net profit (annual)
- ₹7.09 Cr
- P/E (TTM)
- 7.8×Sector 43.1×
- Promoter holding
- 64.44%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Icodex Publishing Solutions Ltd
All →Icodex Publishing Solutions Other Announcement
Icodex Publishing Solutions Ltd has filed its quarterly shareholding pattern as per Regulation 31(1)(b). The document discloses the current shareholding structure of the company.
Icodex Publishing Solutions Annual General Meeting
iCodex Publishing Solutions Limited held its 8th Annual General Meeting on September 30, 2026. Key agenda items included adopting financial statements and changing the company name.
Icodex Publishing Solutions Annual Report
Icodex Publishing Solutions has submitted its Annual Report for the financial year 2025-26 in compliance with SEBI LODR regulations. The report is available on the company's website.
Icodex Publishing Solutions Annual General Meeting
iCodex Publishing Solutions Limited has scheduled its 8th Annual General Meeting for September 30, 2026, via video conferencing to transact ordinary and special business.
Icodex Publishing Solutions Capacity Expansion
Icodex Publishing Solutions is opening a new branch office in Tamil Nadu, effective September 24, 2026, to expand its operational reach.
Icodex Publishing Solutions Management Change
iCodex Publishing Solutions Ltd has appointed Ms. Kajal Patil as the new Chief Financial Officer, effective from September 4, 2026.
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.